Third quarter 2019 results


Sanofi Q3 well on track

Third quarter 2019 results were reviewed by management during a conference call with the financial community.

Since joining Sanofi only two months ago, I am increasingly excited about the strength of our businesses, our ability to develop transformative medicines and the diverse talent of our teams across the organization.

Paul Hudson

Chief Executive Officer

Infographic third quarter 2019 results


Download the audio mp3 file

Q3 2019 presentation

Q3 2019 press release

Q3 2019 income statements

Q3 2019 net sales by GBU, franchise, geographic region and product

Q3 2019 clinical trials appendix

Q3 2019 infographic

Q3 2019 pre-quarterly results communication